Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Renal Care

Therapies

We deliver and support renal therapies across the continuum of care, including the innovative HDx.

Therapies
  • Acute Therapy

    Organ support and blood purification therapies are essential to improving patient outcomes in the ICU.

  • Peritoneal Dialysis

    Peritoneal Dialysis - combined with Remote Patient Management - offers the potential to improve renal patients' clinical outcomes and increase lifestyle flexibility.

  • Hemodialysis

    Hemodialysis is the predominant therapy for end-stage kidney disease, and can be delivered through multiple therapy options.

  • HDx

    HDx - also known as expanded hemodialysis - is an innovative therapy that effectively targets the removal of large middle molecules.

Products

Learn more about Baxter’s key products for Renal Care – across the continuum of care.

Data & Insights

Groundbreaking research and inspirational patient stories.

  • Clinical Data

    Explore the research enabling innovative Renal Care.

  • Stories

    Patients’ journeys inspire our work and drive our commitment.

  • Resource Library

    Access resources for Baxter’s broader Renal Care portfolio.

Explore baxter.com

This global site is intended for Healthcare Professionals only. All products may not be available in all countries. Contact your local Baxter representative

Learn More Clinical Data HDx Other Cozzolino M, Galassi A, Pivari F, Ciceri P, Conte F
Learn More Clinical Data HDx Other Jankowska M, Cobo G, Lindholm B, Stenvinkel P
  • Implementation of HDx, integrated with strategies blocking an excessive secretion of inflammatory mediators, may offer a new therapeutic approach to chronic inflammation and PEW in ESRD
Learn More Clinical Data HDx Other Massy ZA, Liabeuf S
  • Urgent need for clinical trials of interventions designed to decrease levels of these middle molecules in CKD patients
Learn More Clinical Data HDx Other Qian Q
  • Inflammation is an important contributor to both the development and progression of kidney injury. Some of the risk factors potentiating inflammation in the early stages of CKD are readily preventable
Learn More Clinical Data HDx Other Ronco C, Neri M, Lorenzin A, Garzotto F, Clark WR
Learn More Clinical Data HDx Other Clark WR, Gao D, Neri M, Ronco C
  • importance of internal filtration as a solute removal mechanism in high-flux HD is highlighted
Learn More Clinical Data HDx Other Storr M, Boschetti-de-Fierro A, Krause B, Hulko M, Leypoldt K, Girndt M, Fiedler R, Zickler D, Schindler R
  • MCO membranes provide efficient removal of free light chains resulting in significantly decreased predialysis FLC concentrations in the plasma of ESRD patients after 4 week treatment